IL2 and systemic lupus erythematosus: In humans, allelic variants associated with reduced expression of IL-2 or its receptor chains, or genes that impact the IL-2 receptor signaling pathway, have been associated with increased risks of multiple autoimmune and inflammatory diseases, including T1D, SLE, RA, and MS (260–266).